Contra Cancrum Coli is the scientific-practical center, engaged in development of new methods of colon cancer diagnostics and treatment, inventive and.

Slides:



Advertisements
Similar presentations
IntelliDrive for Safety, Mobility, and User Fee Project Cory Johnson Mn/DOT IntelliDrive Program Engineer.
Advertisements

INTERREG and Tacis budgets Main differences: No breakdown of the Tacis budget between the partners is required; No strict limits for the project management.
WAYS PROMOTING QUALITY OF CARDIOLOGIC CARE L.Barbarash, G.Artamonova, S.Makarov Kemerovo, Russia.
Characteristics of Health Care in Limited Access Territories.
Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
Creation of Pilot IP Fund Liis Käosaar-Sasi Dorel Tamm.
Final Report Presentation By Mohammad Saber Sakhizada March,26 – 2009.
Oncologic Results of Laparoscopic Versus Conventional Open Surgery for Stage II or III Left-Sided Colon Cancers A Randomized Controlled Trial A randomized.
Business Planning for Health Organizations ID 536 April 25, 2008 Paul Campbell Harvard School of Public Health.
Chapter 24 The Economics of Prescription Drugs Copyright © 2010 by The McGraw-Hill Companies, Inc. All rights reserved.McGraw-Hill/Irwin.
Dr. ABDULLAH ABDU ALMIKHLAFY Assistant professor & Head of community medicine department Presented By University of Science & Technology Sana’a – Yemen.
FOREST FUEL - RENEWABLE ENERGY. Renewable energy Today, renewable energy is an important part of the Swedish energy budget. With its share in the energy.
Reflection on Problems Concerning Construction of the Health Impact Fund INNOVA P2, New Delhi, 12-13,May2011 Gao Zhiqian Chinese Academy of Science and.
The 5th Globelics Academy Ph.D. School on ‘ National Innovation Systems and Economic Development ’ 2–14 June, 2008, Tampere – Finland Nejla YACOUB Nejla.
Cost Approach FITT (Fostering Interregional Exchange in ICT Technology Transfer)
1/ Thomson Scientific/ 13 July 2015 Investigator Portal.
OHS ORGANIZATION AT WORKPLACES MINISTRY OF LABOR AND SOCIAL SECURITY DIRECTORATE GENERAL OF OHS İsmail ÇELİK OHS Expert.
PATIENT SAFETY IN SURGERY PROF. PANKAJ G. JANI ASSOCIATE PROFESSOR DEPARTMENT OF SURGERY UNIVERSITY OF NAIROBI.
Home Page/Mission Statement Odisha Gateway #1. 2 A Telescopic View: The purpose of the OdishaGateway.org is to build a research database, a repository.
1 Wildcat Venture Management Technology Transfer Tactics Audio Panel September 30, 2008 Chicago, IL Copyright © 2008 Wildcat Venture Management, Inc.
UZBEK ACADEMY OF SCIENCES RENEWABLE ENERGY: PROBLEMS AND PROSPECTIVE IN UZBEKISTAN Ilkham G.Atabaev, Dr of science in physics and mathematics, deputy-director.
STRENGTHENING CENTER FOR PREVENTION IN PRIMARY HEALTH CARE CENTER “ZEMUN” Dr Olivera M. ĆIRKOVIĆ Dr Olivera M. ĆIRKOVIĆ Prof. dr Milica Prostran Dr Mladen.
An Introduction to H IPS HealthCare Infrastructure Professional Services Leading to healthcare. accreditation.
Clinical Research Training
1 Innovation & knowledge indicators  INTERNATIONAL PATENTS  OTHER INDICATORS OF INNOVATION, KNOWLEDGE AND HUMAN CAPITAL.
SoSMSE, Genoa 2014 School of Science Management for Scientists and Engineers GAZZO Serena KACZEREWSKA Olga LAANANI Moussa SALA Leo SALADO Daniela Promising.
PROJECT IDENTIFICATION AND FORMULATION
INTRODUCTION TO RA.
Speech Reconstruction and Neurologic Rehabilitation Center Chairman of the Board of the Private Corporation Medical Network Dobrobut Timoshenko Т. Kyiv.
Health Care In Latvia Current Situation And Challenges In the Future Ingrīda Circene Minister for Health of the Republic of Latvia Riga,
ALL-UKRAINIAN PUBLIC ORGANIZATION “PUBLIC TRANSPORT SAFETY COMMITTEE”
Building of multifunctional geothermal rehabilitation town InterMedicalEcoCity Project goal: «InterMedicalEcoCity» - is an International Medical Rehabilitation.
Medicines and Service Availability and Accessibility in Cancer Care in Georgia 28 th August 2012 Tbilisi Tamari Rukhadze MD. PhD. Oncologist, International.
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
This presentation is Proprietary and no portion of it may be utilized without the permission of Bio- Investigations Ltd. ENHANCING THE VALUATION OF EXTERNALLY-DERIVED.
Science, research and development European Commission IDARI Project Meeting Tartu, June 2005 Martin Greimel Scientific Officer Directorate-E ‘Biotechnology,
Exit Examinations European view M62 Coloproctolgy course, Huddersfield Lars Påhlman Dept. Surgery, Colorectal unit University Hospital, Uppsala, Sweden.
TRACECA CONSTRUCTION OF INTERMODAL TERMINAL IN THE REGION OF RUSE CITY BULGARIA Infrastructure Working Group Kiev, 11 May 2011.
Medical Technology Essential Questions:
The Oxygen Caddie. Rex Lin – Chief Executive Officer Robin Chuang – Vice President Nathaniel Culham – Chief Financial Officer Richard Chan – Chief Operating.
“A HEALTHY OUTSIDE STARTS FROM THE INSIDE” Robert Urich.
Making a top of the best jobs in Romania was quite a tough task because there are a lot of factors, but finally I did it and this is my ‘top 5 jobs’:
Robotics Lesson. Standard  ENGR-II-1: Students will learn the concept of invention and innovation.  ENGR-II-5: Students will examine the impacts of.
EUROPEAN COMMISSION DG EMPL F/3 1 TECHNICAL ASSISTANCE RULE N° 11 OF REGULATION (EC) N° 448/2004 Cristina Asturias, EMPL/F/3.
This work is part of the Joint Action on Improving Quality in HIV Prevention (Quality Action), which has received funding from the European Union within.
Sr. Col. Van Mui Nguyen, Sr. Col. Xuan Kien Nguyen, Sr. Col. Van Cu Ho, Sr. Col. Trung Son Nguyen, Sr. Col. Minh Hieu Nguyen et al Military Institute of.
Intellectual Property Law Unit Four. Patent Right Unit Four.
HEALTH RESEARCHES AND INNOVATIONS IN THE REPUBLIC OF BELARUS MINISTRY OF HEALTH OF THE REPUBLIC OF BELARUS.
0 Ethics Lecture Research. ACADEMY OF OPHTHALMOLOGY Disclosures  The speaker has no financial interest in the subject matter of this.
Methodological Issues in Implantable Medical Device(IMDs) Studies Abdallah ABOUIHIA Senior Statistician, Medtronic.
Epithelial Malignant Tumours of Maxillofacial Region Diagnostics Treatment and Complications. By: Dr Ahmeda Ali.
ERDF for Education and Science th March 2011.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
Skolkovo PRESENTATION
Agenda My Personal Journey The Need For Change Value Measuring Costs
Recent Evolution of New Drug Review and Approval System in Korea
REPURPOSING - SOCIAL IMPACT BONDS FOR MEDICINE
State Audit Bureau of Kuwait
Finance Management End Next.
Mechanisms and tools of technologies transfer
Lessons Learned Through HBD: The Regulator’s View - US FDA
An Industry Perspective Nicole Denjoy COCIR Secretary General
Tbilisi Oncodipensary - Tbilisi Cancer Center
Component 1: Introduction to Health Care and Public Health in the U.S.
Global Biopsy Devices Market Global Biopsy Devices Market.
How Is Precision Medicine Transforming The Health Care Industry?
Personal Appearance is one of the prime factors that bring confidence in an individual. Therefore, people, irrespective of gender, have become more conscious.
Presentation transcript:

Contra Cancrum Coli is the scientific-practical center, engaged in development of new methods of colon cancer diagnostics and treatment, inventive and designing activity, patenting and introduction of inventions. The Center in only person provides the full cycle of creation of medical equipment: from investigation of problem to introduction of product in hospitals. The Center has successfully finished 3 projects of the Ministry of Education and Science of Latvia; now is implementing the project of the Fund for Society Intergration. Centers production – 2 principially new devices: Colonoscope for Colon Cancer Screening (the working model), Intestinal Intubator with Drain and Irrigator (the industrial prototype). Short description of organization

The solving problem The solving problem is concerned with the danger of opening of anastomotic sutures after removal of tumour. The leakage occurs in every 5th patient after urgent surgery and every 8th – after sheduled surgery. The probability of leakage depends on the presence of contents in the intestine. Intestinal Intubator with Drain and Irrigator is a device for surgical treatment of colon cancer. As a whole the complications after urgent operations on account of colon cancer are to be observed in 53% of cases, the mortality – in 32%. Anastomosis

In connection with the presence of intestinal contents and the danger of opening of sutures, the majority of surgeons does not remove a tumour, but bring outside the adducent loop of intestine - create colostomy. After the first operation patient shall have another 1 or 2: removal of tumour, closure of colostomy. The cost of the full cycle of treatment in case of presence of complications could achieve 4 thousands euro. The solving problem Colostomy

Product and its advantages The Intestinal Intubator with Drain and Irrigator: - excludes colostomy, - replaces 2-3 operations by only 1. Removal of tumour during the first operation decreases the probability of spreading of cancerous cells. Introduction of the device will : - reduce the number of complications and mortality, - reduce the treatment expenses, - save patients from psychological and physical problems related to colostomy.

Product and its advantages The device received high estimations of experts of the Academy of Science of Latvia. The device has no analogues. Unique are all 3 systems of device: intubational, drain and irrigation.

Product and its advantages The device is protected by the patents of EPO, EAPO, Ukraine, Latvia; the examination is going in Australia, Canada, China, India, USA.

Market and its potential The consumers of the device will be hospitals: starting from small which provide the urgent surgical aid, up to large which have specialized coloproctology departments.

Market and its potential In Western Europe and the USA colon cancer is among first three places by the mortality rate among oncology diseases. In Latvia the number of colon cancer patients during the last 20 years was doubled. Here is data for evaluating of the market for the Intestinal Intubator with Drain and Irrigator. The consumption of device is defined by the number of hospitals and clinics, which made operations on colon, and by the principle: 1 operating-room – as minimum 2 devices. The price of device is estimated about 2000 eiro. The consumtion of disposable cartridges for the device is defined by the number of operations on colon and by the principle: 1 operation – as minimum 2 cartridges. The price of cartridge is about 150 eiro In countries covered by patent protection live 3,5 mlrd. people.

Achievements of the project The presence of industrial prototype and patents of EPO, EAPO, Ukraine - the most strong arguments on today. Besides, there are following achievements of the project: experiments on 50 big animals, results of preliminary clinical testing of the device, results of bench investigations of safety and effectiveness of industrial prototype of the device, presentation of the device on European exhibitions and medical scientific forums, proposals of a number of hospitals to conduct the trials of the device.

Finances Calculation of expenses on clinical introduction gave the figure of 400 thousands eiro on 3 millions of population. In this sum are included the expenses for: preparation of documentation and receiving of official permittions for clinical application of the device, preparation of technical documentation for the industrial prototype of the device, organization of small-series production of the device, payment of patent fees and patent services, salary, travelling expenses, including the transportation of the equipment, payment to clinics for introduction of the device, training of surgeons, personal and other. Clinical introduction of the device is expedient to conduct parallely in several hospitals. About the organization of introduction thėre is a sense to speak when will be known the concrete intentions and financial possibilities of the investors.

Inventor and Investor – the dream (interpretation of sketch by I. Surovtcev)